ABSTRACT BACKGROUND: Rhodiola rosea (golden root) is a unique phytoadaptagen with immunomodulatory, antioxidant, anti-infl ammatory and antinociceptive activity. AIM: The aim of this study was to evaluate the antinociceptive and anti-infl ammatory effects of the alcohol/water extract of Rhodiola rosea roots in rats. MATERIALS AND METHODS: Thirty male Wistar rats were used in the study. They were divided in 3 groups (n = 10), treated respectively with saline (controls), Rhodiola rosea extract 50 mg/kg bw and 100 mg/kg bw orally. The antinociceptive effect was evaluated using the hot-plate test, Randall-Sellito test and the formalin test. The hot-plate test evaluates the reaction time of rats which are dropped on a heated surface. The analgesy-meter test exerts a force increased at constant rate. In the formalin test we measured the total time spent in licking the injected paw during the early (0-10 min) and late phase (20-30 min) of test. To study anti-infl ammatory effect the carrageenan-induced paw edema was used. The paw volume was measured plethysmometrically at 2, 3 and 4 hours. RESULTS: In the hot-plate test Rhodiola rosea increased in both doses the latency reaction compared with that in the controls. In analgesy-meter test Rhodiola rosea in a dose of 50 mg/kg showed a signifi cant increase of pressure reaction compared with the controls. In the formalin test Rhodiola rosea in a dose of 100 mg/kg signifi cantly decreased the paw licking time during the fi rst phase. In the plethysmometer test Rhodiola rosea extract signifi cantly reduced carrageenan-induced paw edema when compared with the saline-induced edema. CONCLUSION: The studied extract of Rhodiola rosea exhibited signifi cant analgesic activity in all the pain models used -inhibition of thermal pain, mechanical hyperalgesia and formalin-induced pain behavior. Signifi cant anti-infl ammatory activity was observed from Rhodiola rosea extract in carrageenan induced paw edema in rats.
INTRODUCTION
Rhodiola rosea (Golden Root) is a unique phytoadaptogen that grows in high-altitude regions. Recently it has gained medical attention because of its various therapeutic properties. 1 Rhodiola rosea L. is one of the most popular adaptogens and an antistress plant in European and Asiatic traditional medicine. 2 Studies have found that Rhodiola preparations exhibit adaptogenic effect including neuroprotective, cardioprotective, anti-fatigue, antidepressive, anxiolytic, nootropic, life-span increasing effects and CNS stimulating activity. 3 Its pharmacological properties appear to depend on its ability to modulate the activation of several components of the complex stress-response system. 4 
AIM
The aim of the study was to evaluate the antinociceptive and anti-infl ammatory effects of the alcohol/ water extract of Rhodiola rosea roots in rats.
MATERIALS AND METHODS
Male Wistar rats weighing 170-210 g were divided into 3 groups (n = 10). The rats were kept under standard laboratory conditions in a 08:00-20:00 h light/dark cycle and were provided with food and water ad libitum. The test substance was administered by oral gavage. The following experimental groups were used: group 1 received saline (0.1 ml/100 g b. w.); group 2 -50 mg/kg of Rhodiola rosea; group 3 -100 mg/kg of Rhodiola rosea. The extract of Rhodiola rosea we studied was evaluated by the research group of Phytochemistry Division in the Institute of Botany, Bulgarian Academy of Science. 5, 6 The method used was HPLC on Aligent 1100 Series HPLC System with MWD UV-Vis detector. The extract was 80/20% water/ alcohol, as described previously. The natural origin voucher specimens and all botanical information were obtained.
HOT-PLATE TEST
The original hot plate set up (Ugo Basile, Italy) was used. A transparent glass cylinder was used to keep the rat on the heated surface of the plate. The temperature of the hot plate was set to 55 ± 0.5 °C. Latency time was defi ned as the time between the zero point when the animal was placed on the hot plate surface and the time when the animal licked its hind paw or jumped off to avoid thermal pain. The accepted "zero time" in this study started 30 min after drug administration. To minimize tissue damage, a cut-off time of 30 sec was adopted. The latencies of both forepaws licking or jumping were measured for each animal at 0, 60, 120 and 180 minutes.
NOCICEPTIVE TEST
The original analgesy-meter set up (Ugo Basile, Italy) was used. The antinociceptive effect of Rhodiola rosea was assessed using a mechanical noxious stimulus as previously described by Randall & Selitto. 7 Nociceptive threshold, expressed in grams, was measured in centimeters by applying an increasing pressure to the right hind paw of unrestrained rats until the rat squeaked and/or a struggle was obtained. The rats were tested at 0, 1, 2 and 3 hours after p.o. administration of the test substance.
FORMALIN TEST
In the formalin test formalin (0.1 ml, 2%) was injected into the plantar surface of the left hind paw. Each animal was placed in an observation chamber and nociceptive response was recorded for a period of 30 min. The sum of time (in s) spent in licking and biting the injected paw in the fi rst 10 min and that from 20 min to 30 min was taken as an indicator of nociceptive response. 8 
ANTI-INFLAMMATORY TEST
To study the anti-infl ammatory effect the carrageenan-induced paw edema was used. Paw edema was induced by injecting 0.1 ml of 1% solution sterile carrageenan lambda in saline into the right hind paw of the rat. 9 Carrageenan caused visible redness and pronounced swelling that was well developed within 4 hours and persisted for more than 48 hours. The rats received vehicle or Rhodiola rosea (p.o.) 30 min before carrageenan administration. Hind footpad thickness was measured immediately before carrageenan injection and at 2, 3 and 4 hours thereafter with a plethysmometer.
STATISTICAL ANALYSIS
The results obtained were expressed as mean ± SEM. The comparison between the groups was made by Student's t-test of analysis of variance (one way ANOVA), in the INSTAT computer program. Tukey-Kramer Multiple Comparison Test was used to compare each parameter of the respective experimental group with the control group. A value P < 0.05 was considered as statistically signifi cant.
For the anti-infl ammatory test the difference between two readings was taken as the volume of edema, and the percentage of anti-infl ammatory activity was calculated using the following equation:
Percentage of anti-infl ammatory activity = (V-V 0 )/V 0 ×100, where V is the paw volume at 1, 2, 3 and 4 hours after the carrageenan injection and V 0 is the initial paw volume.
RESULTS

ANTINOCICEPTIVE ACTIVITY
In the hot plate analgesic test the average latency of the controls was between 12 and 20 sec. The animals treated with Rhodiola rosea at both doses increased the latency reaction at 2 and 3 hours (p < 0.05) as compared with the respective control group (Fig. 1) .
In the analgesy-meter test the control animals showed average pressure reaction between 10 and 13 cm. Rats treated with 50 mg/kg of Rhodiola rosea showed a signifi cant increase (p < 0.05) of pressure reaction at 1, 2 and 3 hours as compared with the respective control group. The group treated with 100 mg/kg of test substance showed an increase of pressure reaction at 1 hour (p < 0.05) as compared with the respective controls (Fig. 2) .
In the formalin test the duration of paw licking reaction for the controls was 43 sec for the fi rst phase and 31 sec for the second phase. The group treated with 50 mg/kg of Rhodiola rosea showed no change of paw licking duration during the fi rst and second phases. The rats treated with 100 mg/kg of test substance signifi cantly decreased (p < 0. the duration of licking during the fi rst phase and did not change it during the second phase (Fig. 3) .
ANTI-INFLAMMATORY ACTIVITY
Carrageenan administered in control rats caused visible redness and pronounced swelling that was well developed within 4 hours and persisted for more than 48 hours. Rats treated with 50 mg/kg of Rhodiola rosea showed inhibition of carrageenan-induced paw edema (p < 0.05) at 4 hours as compared with the respective controls. Animals treated with 100 mg/ kg of test substance signifi cantly decreased (p < 0.05) the paw volume at 3 and 4 hours (Fig. 4) . 
DISCUSSION
Based on the results of this study we can assume that the extract of Rhodiola rosea we studied has an antinociceptive effect because it increases the latency of reaction at 2 and 3 hours in the hot plate test. The extract of Rhodiola rosea exerts an analgesic effect on mechanical hyperalgesia assessed with the Randall-Selitto paw pressure test widely used for qualifi cation of the thresholds of the rat high paw withdrawal refl ex to nociceptive pressure stimulation. The extract of Rhodiola rosea does not have a well pronounced suppressive ef- fect in the formalin test. Only the number of paw licking during the early phase decreased when the higher dose of the substance was used. The formalin test is considered to be the most predictive of acute pain and is believed to be a more valid model for clinical pain. 10 Our results also showed that oral administration of Rhodiola rosea extract inhibited carrageenan-induced infl ammatory pain. Carrageenan-induced infl ammatory pain is wellknown to involve inflammatory mediators like cyclooxygenase products (PG E 2 ), leucotriennes, mast sells products (histamine, 5-HT), nitric oxide, etc. which are released as a result of tissue injury. 11 Pooja et al. studied the anti-infl ammatory activity of the tincture extract of Rhodiola rosea roots through carrageenan-induced paw edema, formaldehydeinduced arthritis and nystatin-induced paw edema in a rat model. 1 They found that the tincture extract exhibited an inhibitory effect against acute and subacute infl ammation at a dose of 250 mg/kg body weight. Inhibition of nystatin-induced edema was also observed in a dose-dependent manner. The in vitro inhibitory effects of the tincture extract from Rhodiola rosea roots was evaluated against the enzymes relating to infl ammation. The enzymes include cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2) and phospholipase A2 (PLA2). The extract showed varying inhibitory activities against these enzymes depending on the concentrations. A potent inhibition was observed against COX-2 and PLA-2. Inhibition of nystatin-induced edema and phospholipase A2 suggested that membrane stabilization could be the most probable mechanism of action of Rhodiola rosea in anti-infl ammation. 1 The fi ndings in many studies suggest that Rhodiola rosea root extract can be used in the treatment of infl ammatory conditions. Several mechanisms of action possibly contributing to the clinical effect have been identifi ed for Rhodiola extracts. They include interactions with HPA-system (cortisolreducing), protein kinases p-JNK, nitric oxide, and defense mechanism proteins (e. g. heat shock proteins Hsp 70 and FoxO/DAF-16). 3 Rhodiola rosea was shown to have high potential for singlet oxygen scavenging, hydrogen peroxide scavenging, ferric reducing, ferrous chelating and protein thiol protection. 12 Rhodioloside and Rhodiola rosea were the most active inhibitors of stress-induced p-SAPK/p-JNK. 13 Our results are in support of such suggestion.
CONCLUSIONS
The studied extract of Rhodiola rosea exhibited signifi cant analgesic activity in all the pain models used -inhibition of thermal pain, mechanical hyperalgesia and formalin-induced pain behavior. Signifi cant anti-infl ammatory activity was observed from Rhodiola rosea extract in carrageenan induced paw edema in rats. The antinociceptive effect is probably induced by inhibition of COX enzyme and PLA2, and the anti-infl ammatory effect -by infl uencing HPA-system, nitric oxide and some other defense proteins.
